---
title: "12 Health Care Stocks Moving In Friday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295262147.md"
description: "On Friday, several healthcare stocks experienced significant intraday volatility following earnings reports. Gainers included AVITA Medical (+58.4%), Embecta (+32.4%), and Starling Oncology (+32.1%). Conversely, losers featured CVRx (-57.8%), Organogenesis Holdings (-29.9%), and BioVie (-25.1%). Most movements were driven by the release of quarterly earnings data."
datetime: "2026-08-07T17:05:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295262147.md)
  - [en](https://longbridge.com/en/news/295262147.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295262147.md)
---

# 12 Health Care Stocks Moving In Friday's Intraday Session

### Gainers

-   **AVITA Medical** (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.
-   **Embecta** (NASDAQ:EMBC) stock moved upwards by 32.42% to $4.63. The market value of their outstanding shares is at $207.2 million. As per the news, the Q3 earnings report came out today.
-   **Starling Oncology** (NASDAQ:STLN) shares rose 32.06% to $6.59. The market value of their outstanding shares is at $498.9 million.
-   **Doximity** (NYSE:DOCS) shares moved upwards by 31.65% to $27.2. The company's market cap stands at $3.7 billion. The company's, Q1 earnings came out yesterday.
-   **Senseonics Holdings** (NASDAQ:SENS) stock rose 24.85% to $6.43. The market value of their outstanding shares is at $268.8 million. The company's, Q2 earnings came out yesterday.
-   **OmniAb** (NASDAQ:OABI) shares moved upwards by 22.37% to $2.74. The company's market cap stands at $324.7 million. The company's, Q2 earnings came out yesterday.

### Losers

-   **CVRx** (NASDAQ:CVRX) stock declined by 57.8% to $2.5 during Friday's regular session. The company's market cap stands at $157.6 million. The company's, Q2 earnings came out yesterday.
-   **Organogenesis Holdings** (NASDAQ:ORGO) stock decreased by 29.88% to $1.69. The market value of their outstanding shares is at $310.1 million. As per the news, the Q2 earnings report came out yesterday.
-   **BioVie** (NASDAQ:BIVI) stock decreased by 25.12% to $1.01. The company's market cap stands at $10.1 million.
-   **Health Catalyst** (NASDAQ:HCAT) stock declined by 24.9% to $1.74. The company's market cap stands at $170.6 million. The company's, Q2 earnings came out yesterday.
-   **QuidelOrtho** (NASDAQ:QDEL) shares fell 23.04% to $12.56. The company's market cap stands at $1.1 billion. As per the press release, Q2 earnings came out yesterday.
-   **Autonomix Medical** (NASDAQ:AMIX) shares fell 20.34% to $9.7. The company's market cap stands at $6.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CVRX.US](https://longbridge.com/en/quote/CVRX.US.md)
- [EMBC.US](https://longbridge.com/en/quote/EMBC.US.md)
- [RCEL.US](https://longbridge.com/en/quote/RCEL.US.md)
- [STLN.US](https://longbridge.com/en/quote/STLN.US.md)
- [BIVI.US](https://longbridge.com/en/quote/BIVI.US.md)
- [ORGO.US](https://longbridge.com/en/quote/ORGO.US.md)
- [DOCS.US](https://longbridge.com/en/quote/DOCS.US.md)
- [SENS.US](https://longbridge.com/en/quote/SENS.US.md)
- [OABI.US](https://longbridge.com/en/quote/OABI.US.md)
- [HCAT.US](https://longbridge.com/en/quote/HCAT.US.md)
- [QDEL.US](https://longbridge.com/en/quote/QDEL.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [OABIW.US](https://longbridge.com/en/quote/OABIW.US.md)
- [BIVIW.US](https://longbridge.com/en/quote/BIVIW.US.md)

## Related News & Research

- [CVRx (NASDAQ:CVRX) Announces Quarterly Earnings Results](https://longbridge.com/en/news/295181057.md)
- [Organogenesis enters $75 million at-the-market equity sales agreement](https://longbridge.com/en/news/295151249.md)
- [RCEL: Sequential growth, margin discipline, and new reimbursement drive optimism for future profitability](https://longbridge.com/en/news/295670276.md)
- [CVRx Q2 revenue beats estimates, outlook cut on sales force, payer challenges](https://longbridge.com/en/news/295142307.md)
- [Embecta (NASDAQ:EMBC) Updates FY 2026 Earnings Guidance](https://longbridge.com/en/news/295225377.md)